Literature DB >> 2146348

Phenotypes and functions of lymphocytes in congenital toxoplasmosis.

R McLeod1, D G Mack, K Boyer, M Mets, N Roizen, C Swisher, D Patel, E Beckmann, D Vitullo, D Johnson.   

Abstract

Comparisons of lymphocyte surface phenotypes and functions were made among 25 pediatric patients with congenital toxoplasmosis (ages 1 month to 5 years) and 24 uninfected babies, a baby with postnatally acquired infection, and 6 uninfected, 7 recently infected, and 6 chronically infected adults. Percentages of lymphocytes with B1, T11, T3, T4, T8, T6, B4, Ia, NKH phenotypes and T4 to T8 ratios of infected and uninfected babies were the same (p greater than 0.05). Lymphocytes from congenitally infected babies had lower blastogenic responses (mean stimulation index [SI] = 5) to Toxoplasma lysate antigens (TLA) than lymphocytes from adult control groups with recent and chronic infection (Mean SIs = 32, 72; p less than 0.001). Compared to infected adults, congenitally infected children had similar or greater responses to concanavalin A (mean SIs = 94; 118, 76, p greater than 0.05) and in mixed leukocyte culture (mean SIs = 63; 22, 26, p greater than 0.05). For symptomatic babies, low blastogenic response to TLA correlated with more severe disease at presentation (p = 0.002). Lymphocyte blastogenic responses to TLA were increased for most children when they were older than 15 months, but responses remained less than adult levels for 9 of the 17 older children studied. There was no correlation between concomitant serum pyrimethamine levels and lymphocyte blastogenic responses to TLA. Pyrimethamine and sulfonamide treatment in vitro and in vivo did not alter lymphocyte response to TLA. Lymphocytes from congenitally infected babies failed to produce either gamma interferon or Interleukin 2 when cultured with TLA. In contrast, they produced these lymphokines when cultured with concanavalin A or phytohemagglutinin. Specific deficits in cell-mediated immune responses to TLA may account for the significant organ damage that occurs in infants and children with congenital toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2146348

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  15 in total

Review 1.  The immunology of parasite infections in immunocompromised hosts.

Authors:  T Evering; L M Weiss
Journal:  Parasite Immunol       Date:  2006-11       Impact factor: 2.280

2.  Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii.

Authors:  Samantha R Béla; Míriam S Dutra; Ernest Mui; Alexandre Montpetit; Fernanda S Oliveira; Sérgio C Oliveira; Rosa M E Arantes; Lis R Antonelli; Rima McLeod; Ricardo T Gazzinelli
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

3.  Cellular immunity to Toxoplasma gondii in congenitally infected newborns and immunocompetent infected hosts.

Authors:  A F Fatoohi; G J N Cozon; M Wallon; S Kahi; F Gay-Andrieu; T Greenland; F Peyron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-04       Impact factor: 3.267

4.  Resistance to Toxoplasma gondii in mice infected as neonates or exposed in utero.

Authors:  L L Johnson
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis.

Authors:  Elizabeth Torres-Morales; Laura Taborda; Nestor Cardona; Alejandra De-la-Torre; Juan Carlos Sepulveda-Arias; Manuel Alfonso Patarroyo; Jorge Enrique Gomez-Marin
Journal:  Med Microbiol Immunol       Date:  2014-05-11       Impact factor: 3.402

6.  Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase.

Authors:  Gang Cheng; Stephen P Muench; Ying Zhou; Gustavo A Afanador; Ernest J Mui; Alina Fomovska; Bo Shiun Lai; Sean T Prigge; Stuart Woods; Craig W Roberts; Mark R Hickman; Patty J Lee; Susan E Leed; Jennifer M Auschwitz; David W Rice; Rima McLeod
Journal:  Bioorg Med Chem Lett       Date:  2013-02-13       Impact factor: 2.823

7.  Human V delta 2+ gamma delta T-cell tolerance to foreign antigens of Toxoplasma gondii.

Authors:  T Hara; S Ohashi; Y Yamashita; T Abe; H Hisaeda; K Himeno; R A Good; K Takeshita
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

8.  Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay.

Authors:  Gustavo A Afanador; Stephen P Muench; Martin McPhillie; Alina Fomovska; Arne Schön; Ying Zhou; Gang Cheng; Jozef Stec; Joel S Freundlich; Hong-Ming Shieh; John W Anderson; David P Jacobus; David A Fidock; Alan P Kozikowski; Colin W Fishwick; David W Rice; Ernesto Freire; Rima McLeod; Sean T Prigge
Journal:  Biochemistry       Date:  2013-12-13       Impact factor: 3.162

9.  Mitogen- and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates.

Authors:  E Candolfi; C A Hunter; J S Remington
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

10.  Phenotypic profile and functional characteristics of human gamma and delta T cells during acute toxoplasmosis.

Authors:  P De Paoli; G Basaglia; D Gennari; M Crovatto; M L Modolo; G Santini
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.